The Development of a Cross-strain and Cross-subtype Pre Pandemic Influenza Vaccine using Savine Technology [ 2009 - 2009 ]

Research Grant

Researchers: Prof Ian Ramshaw (Principal investigator) ,  The Australian National University (Managed by)

Brief description The flu vaccines in use today work by inducing antibodies to surface proteins. Flu causes disease every year but occasionally a new strain arises that is distincly differnet from previous strains and can cause wides spread disease and deaths worldwide. Our new approach is to increase the level of T cells that can recognise and kill flu infected cells from all flu strains.

Funding Amount $AUD 159,500.00

Funding Scheme NHMRC Development Grants

Notes Development Grant